603367 辰欣藥業
按盤價 
23.270 +2.120 (+10.024%) | 2025/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 1,739,773 | -15.97% | 3,981,572 | 4,462,349 | 4,066,088 | 3,782,593 | |
| 減：營業總成本 | 1,493,370 | -17.06% | 3,483,463 | 3,866,683 | 3,717,618 | 3,536,814 | |
| 其中:營業成本 | 762,687 | -12.82% | 1,729,094 | 1,839,024 | 1,789,293 | 1,684,647 | |
| 財務費用 | (12,036) | -29.96% | (32,483) | (33,671) | (27,876) | (9,084) | |
| 資產減值損失 | (44,149) | 16.87% | (56,026) | (73,497) | (16,462) | (21,297) | |
| 公允價值變動收益 | 20,860 | 147.59% | 10,528 | (10,375) | (3,120) | (6,090) | |
| 投資收益 | 34,665 | 89.31% | 62,304 | 44,118 | 18,680 | 72,513 | |
| 其中：對聯營企業和合營企業的投資收益 | 14 | 11,434.98% | (484) | 132 | (753) | 4,166 | |
| 營業利潤 | 256,735 | -11.51% | 572,048 | 592,578 | 364,583 | 334,421 | |
| 利潤總額 | 256,450 | -12.19% | 575,773 | 595,857 | 366,191 | 336,132 | |
| 減：所得稅費用 | 25,162 | 37.15% | 60,833 | 70,430 | 13,920 | 2,230 | |
| 淨利潤 | 231,288 | -15.50% | 514,940 | 525,426 | 352,271 | 333,902 | |
| 減：非控股權益 | 2,137 | -37.13% | 6,034 | 4,088 | 2,313 | (245) | |
| 股東淨利潤 | 229,151 | -15.23% | 508,906 | 521,338 | 349,959 | 334,146 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.510 | -15.00% | 1.120 | 1.150 | 0.770 | 0.740 | |
| 每股派息 (元) * | 0.188 | -14.55% | 0.440 | 0.436 | 0.335 | 0.300 | |
| 每股淨資產 (元) * | 13.440 | 4.79% | 13.141 | 12.649 | 11.763 | 11.150 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 17/10/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
